miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 12, 2026

Oracle Corporation (ORCL) Investors: Kessler Topaz Meltzer & Check, LLP Announces that the Firm has Filed a Securities Fraud Class Action Lawsuit Against Oracle Corporation and Encourages Investors to Contact the Firm

View original at globenewswire.com
Oracle Corporation (ORCL) Investors: Kessler Topaz Meltzer & Check, LLP Announces that the Firm has Filed a Securities Fraud Class Action Lawsuit Against Oracle Corporation and Encourages Investors to Contact the Firm RADNOR, Pa., Feb…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Oracle's $248 billion lease commitment disclosure is a bombshell disclosure, with lease commitments increasing massively from just under $100 billion in the prior quarter

    80% confidence
  • Oracle pushed back completion dates for data centers developing for OpenAI to 2028 from 2027 due to labor and material shortages

    80% confidence
  • Oracle's future lease exposure far exceeds similar commitments by peers, with a mismatch between the long duration of the property leases and much shorter contracts with key customers such as OpenAI

    80% confidence
  • Oracle has very good line-of-sight for capabilities to spend on CapEx right before it starts generating revenue

    80% confidence
  • OpenAI could account for more than a third of total Oracle revenues by fiscal 2028 and even a greater share by fiscal 2030

    80% confidence
  • Oracle really matters because it is the harbinger of the AI capex boom, and this repricing in debt markets is very consistent with the view that risks are building

    80% confidence
  • Blue Owl Capital pulled out of funding a $10 billion Oracle data center intended to serve OpenAI as a result of concerns about Oracle's spending commitments and rising debt levels

    80% confidence
  • Oracle's AI infrastructure strategy would result in massive increases in CapEx without equivalent, near-term growth in revenue; the Company's substantially increased spending created serious risks involving Oracle's debt and credit rating, free cash flow, and ability to fund its projects

    80% confidence
  • The Company's substantially increased spending on AI infrastructure would rapidly convert into accelerating revenue and profit growth

    80% confidence
  • Oracle's promises of massive new revenues from its increased AI infrastructure business were unlikely to materialize

    80% confidence
  • Oracle stock price target of $175, representing a 40% pullback

    80% confidence
  • OpenAI's ability to meet contractual obligations will be contingent on AI tailwinds continuing and its models being a market leader to continue to raise external financing

    80% confidence
  • Oracle expects to spend less than $100 billion on AI growth plans

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Oracle Corporation (ORCL) Investors: Kessler Topaz Meltzer & Check, LLP Announces that the Firm has Filed a Securities Fraud Class Action Lawsuit Against Oracle Corporation and Encourages Investors to Contact the Firm — Source | Via News | es.VIA.NEWS